GRAIL, Inc. Shareholders' Equity
GRAIL, Inc. (GRAL) had Shareholders' Equity of $2.54 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $2.54B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.50B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.58B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.24B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $2.54B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.50B 10-Q · filed 2026-08-06 |
| 2025-12-31 | $2.58B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.24B 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.31B 10-Q · filed 2026-08-06 |
| 2025-03-31 | $2.41B 10-Q · filed 2026-08-06 |
| 2024-12-31 | $2.50B 10-Q · filed 2026-08-06 |
| 2024-09-30 | $2.59B 10-Q · filed 2025-11-13 |
| 2024-06-30 | $2.70B 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |